BT
Brajkishor Tiwari
About Brajkishor Tiwari
Data last updated:
Brajkishor Tiwari is a Director at Curedose Pharma Labs Private Limited (since 2023). Curedose Pharma Labs Private Limited reported revenue of ₹8.9 Lakh (FY 2025). Earlier, Brajkishor Tiwari was a Director at Roxio Healthcare Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curedose Pharma Labs Private Limited U46497MP2023PTC068745 | Director | 28 Nov 2023 | 2023 | ₹8.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Roxio Healthcare Private Limited U24233MP2012PTC027901 | Director | 06 Mar 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Brajkishor Tiwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Mishra | 10407287 | Curedose Pharma Labs Private Limited | Director |
| Divya Gupta | 00236773 | Curedose Pharma Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brajkishor Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brajkishor Tiwari
Brajkishor Tiwari currently holds 1 directorship: Curedose Pharma Labs Private Limited (Director, since 28 Nov 2023, revenue ₹8.9 Lakh (FY 2025)).
Brajkishor Tiwari was first appointed on 06 Mar 2012 as Director at Roxio Healthcare Private Limited. The most recent appointment on record is 28 Nov 2023 at Curedose Pharma Labs Private Limited.
Brajkishor Tiwari held 1 earlier board appointment: Roxio Healthcare Private Limited (Director, from 06 Mar 2012).
The current boards of Brajkishor Tiwari's companies include Ashish Mishra (Curedose Pharma Labs Private Limited), Divya Gupta (Curedose Pharma Labs Private Limited).